The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of VTE on mortality in patients with stage III colon cancer.
C. D. Mullins
Consultant or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Genentech; Novartis; Otsuka; Pfizer; Sanofi
Research Funding - Novartis; Pfizer; Sanofi
K. A. Bikov
No relevant relationships to disclose
D. L. McNally
No relevant relationships to disclose
N. C. Onwudiwe
No relevant relationships to disclose
M. R. Dalal
Employment or Leadership Position - Sanofi
N. Hanna
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi